---
title: "On September 10th, Li Li, the director of the National Medical Products Administration of China, met"
description: "On September 10th, Li Li, the director of the National Medical Products Administration of China, met with Cai Ruifen, the director of the Health Sciences Authority of Singapore. The two sides had in-d"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256720441.md"
published_at: "2025-09-10T10:38:50.000Z"
---

# On September 10th, Li Li, the director of the National Medical Products Administration of China, met

> On September 10th, Li Li, the director of the National Medical Products Administration of China, met with Cai Ruifen, the director of the Health Sciences Authority of Singapore. The two sides had in-depth exchanges on strengthening cooperation in the regulation of pharmaceuticals and medical devices. Li Li introduced the situation of drug regulation and the development of the pharmaceutical industry in China, emphasizing the importance of ensuring drug quality and safety. Cai Ruifen introduced Singapore's drug regulatory functions and international cooperation. Both sides agreed to deepen practical cooperation, jointly enhance the quality and effectiveness of drug regulation, and improve the health and well-being of the people of both countries

On September 10th, Li Li, the director of the National Medical Products Administration, met with a delegation led by Cai Ruiwen, the director of the Health Sciences Authority of Singapore, in Beijing. Both sides conducted in-depth exchanges on further strengthening cooperation in the regulation of pharmaceuticals and medical devices between China and Singapore. Li Li introduced the work of drug regulation in China and the development of the pharmaceutical industry. He stated that in recent years, the National Medical Products Administration has consistently adhered to ensuring the quality and safety of drugs as its fundamental responsibility, continuously deepening the reform of the drug review and approval system, strengthening the construction of drug regulatory capabilities, and comprehensively promoting the scientific, legal, international, and modern development of drug regulation. Cai Ruiwen introduced the functions of the Health Sciences Authority of Singapore, its drug regulation work, and its participation in international drug regulatory coordination, as well as the establishment of trust and cooperation mechanisms with relevant countries in the field of drug and medical device review. The two sides exchanged views on promoting mutual trust in drug and medical device regulation between China and Singapore, as well as the regulation of traditional Chinese medicine. Both parties agreed to further deepen practical cooperation in the field of drug regulation to jointly enhance the quality and effectiveness of drug regulation and better promote the health and well-being of the people of both countries

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 手眼通天！爱泼斯坦曾帮罗斯柴尔德家族 “搞定” 美国司法部交易，获利 2500 万美元 | 这位声名狼藉的掮客不仅协助阿丽亚娜·德·罗斯柴尔德摆平监管危机，更深度介入家族内部的 “夺权” 大戏与资本运作。最新解密的文件，揭示了顶级名利场中，法律边缘的灰色交易与脆弱的人性依赖。 | [Link](https://longbridge.com/en/news/275225674.md) |
| 市场监管总局约谈阿里巴巴、抖音、百度、腾讯、京东、美团、淘宝闪购等平台企业 | 市场监管总局于 2 月 13 日约谈了阿里巴巴、抖音、百度、腾讯、京东、美团和淘宝闪购等平台企业，要求它们遵守相关法律法规，落实主体责任，规范促销行为，并杜绝 “内卷式” 竞争，以维护公平竞争市场环境，促进平台经济的创新与健康发展。 | [Link](https://longbridge.com/en/news/275975190.md) |
| Outset Medical｜8-K：2025 财年 Q4 营收 28.87 百万美元不及预期 |  | [Link](https://longbridge.com/en/news/275659348.md) |
| 国会再度质询 “爱泼斯坦”，美国商务部长 “改口” 承认：2012 年曾上岛 | 美国商务部长 Lutnick 听证会 “翻车”，承认 2012 年曾携家人登上爱泼斯坦私人岛屿用餐，与此前 “2005 年后划清界限” 的说法自相矛盾。尽管白宫力挺，但司法部文件揭露其后续仍有商业往来，诚信危机引发国会两党议员集体施压要求其 | [Link](https://longbridge.com/en/news/275529955.md) |
| 西氏医药服务｜8-K：2025 财年 Q4 营收 8.05 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/275755021.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.